vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 36.65 USD 1.78% Market Closed
Market Cap: 144.4m USD

Wall Street
Price Targets

VTVT Price Targets Summary
vTv Therapeutics Inc

Wall Street analysts forecast VTVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTVT is 41.48 USD with a low forecast of 35.35 USD and a high forecast of 49.35 USD.

Lowest
Price Target
35.35 USD
4% Downside
Average
Price Target
41.48 USD
13% Upside
Highest
Price Target
49.35 USD
35% Upside
vTv Therapeutics Inc Competitors:
Price Targets
TVTX
Travere Therapeutics Inc
16% Upside
OPK
OPKO Health Inc
181% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
52% Upside
LGND
Ligand Pharmaceuticals Inc
25% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
26% Upside
CANTA
Cantargia AB
102% Upside
RLYB
Rallybio Corp
30% Upside
CYTK
Cytokinetics Inc
27% Upside

Revenue
Forecast

Revenue Estimate
vTv Therapeutics Inc

For the last 10 years the compound annual growth rate for vTv Therapeutics Inc's revenue is -4%. The projected CAGR for the next 4 years is 55%.

-4%
Past Growth
55%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTVT's stock price target?
Price Target
41.48 USD

According to Wall Street analysts, the average 1-year price target for VTVT is 41.48 USD with a low forecast of 35.35 USD and a high forecast of 49.35 USD.

What is vTv Therapeutics Inc's Revenue forecast?
Projected CAGR
55%

For the last 10 years the compound annual growth rate for vTv Therapeutics Inc's revenue is -4%. The projected CAGR for the next 4 years is 55%.

Back to Top